Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

676 to 700 of 921 results

Validus Pharma gets rights to six Novartis drugs in USA

19-11-2012

USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired…

GenericsMergers & AcquisitionsNovartisValidus Pharma

Geron signs tentative deal with BioTime on stem cell assets

18-11-2012

A year after announcing its decision to exit stem cell therapy, the USA's Geron Corp (Nasdaq: GERN) has…

BiotechnologyBioTimeFinancialGeron CorpMergers & Acquisitions

Allergan to acquire SkinMedica business for $350 million

18-11-2012

US drug firm Allergan (NYSE: AGN), best known as the maker Botox (onabotulinumtoxinA) anti-wrinkle injections,…

AllerganDermatologicalsMergers & AcquisitionsPharmaceuticalSkinMedica

Reckitt Benckiser trumps Bayer's bid for control of Schiff Nutritional

16-11-2012

In a move that looks set to thwart Germany-based Bayer's (BAYN: DE) plans to acquire the US nutritional…

BayerMergers & AcquisitionsPharmaceuticalReckitt BenckiserSchiff Nutrition International

AFK Sistema cleared to take over Russian drugmaker Veropharm

14-11-2012

Shares in Russian companies 36.6 and Veropharm surged in Monday afternoon trading on the Moscow Stock…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalRegulationVeropharm

Myrexis board approves liquidation and dissolution plan

12-11-2012

US cancer and autoimmune diseases drug developer Myrexis (Nasdaq: MYRX) said on Friday that its board…

FinancialMergers & AcquisitionsMyrexisPharmaceutical

Sun Pharma to acquire DUSA Pharmaceuticals for $230 million

09-11-2012

India's Sun Pharmaceutical Industries (SUN.BO) has entered into a definitive agreement to acquire US…

DermatologicalsDUSA PharmaceuticalsLevulanMergers & AcquisitionsPharmaceuticalSun Pharmaceutical Industries

Immune Pharmaceuticals to acquire EpiCept under stock merger accord

08-11-2012

Privately-held Israeli company Immune Pharmaceuticals and US drug developer EpiCept Corp (Nasdaq: EPCT)…

EpiCeptImmune PharmaceuticalsInflammatory diseasesMergers & AcquisitionsOncologyPharmaceutical

Otsuka Pharma sets up joint venture in Turkey

07-11-2012

Otsuka Pharmaceutical (TYO: 4768), a mid-size Japanese drugmaker, and Abdi ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������°brahim…

Abdi IbrahimEuropeMarkets & MarketingMergers & AcquisitionsOtsukaPharmaceutical

Another acquisition for Takeda, Envoy Therapeutics for up to $140 million

07-11-2012

Takeda Pharmaceutical (TYO: 4502), Japan's largest drugmaker, has clearly not quenched its thirst for…

Envoy TherapeuticsMergers & AcquisitionsNeurologicalPharmaceuticalTakeda Pharmaceuticals

Exonhit to acquire InGen BioSciences for 18 million euros

07-11-2012

French drug discovery and development firm Exonhit Therapeutics (ALEHT:FP) has entered into an agreement…

DiaxonhitExonhit TherapeuticsInGen BioSciencesMergers & AcquisitionsPharmaceutical

AFK Sistema may acquire Russian drugmaker Veropharm

06-11-2012

AFK Sistema, the financial conglomerate owned by the Russian billionaire Vladimir Yevtushenko, is considering…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalVeropharm

Charles River Labs to buy majority stake in China's Vital River

31-10-2012

USA-based Charles River Laboratories International (NYSE:CRL) has entered into an agreement to acquire…

Asia-PacificCharles River LaboratoriesMergers & AcquisitionsPharmaceuticalVital River

Allergan 4th-qtr revenues up 6%; earnings exceed expectations

31-10-2012

US health care firm Allergan (NYSE: AGN) revealed yesterday that revenues for its fiscal fourth-quarter…

AllerganFinancialMergers & AcquisitionsPharmaceutical

Revised terms for ViiV Healthcare and Shionogi HIV partnership

30-10-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says that Healthcare, its HIV/AIDS joint venture with Pfizer,…

Anti-viralsdolutegravirGlaxoSmithKlineMergers & AcquisitionsPfizerPharmaceuticalShionogiViiV Healthcare

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics

24-10-2012

Spain's largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech…

AB-BioticsAlmirallBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Pfizer to buy NextWave Pharma for as much as $680 million

23-10-2012

Global drugs behemoth Pfizer (NYSE: PFE) revealed yesterday that it is prepared to pay up to $680 million…

GenericsMergers & AcquisitionsNextWave PharmaceuticalsPfizerPharmaceuticalQuillivant

BioCryst and Presidio to merge, creating new competitor in HCV arena

22-10-2012

USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately…

Anti-viralsBioCryst PharmaceuticalsMergers & AcquisitionsPharmaceuticalPresidio Pharmaceuticals

676 to 700 of 921 results

Back to top